Teacher Retirement System of Texas Grows Stock Position in Kenvue Inc. (NYSE:KVUE)

Teacher Retirement System of Texas boosted its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 62.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 501,448 shares of the company's stock after purchasing an additional 192,981 shares during the quarter. Teacher Retirement System of Texas' holdings in Kenvue were worth $12,025,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Fulton Bank N.A. lifted its position in Kenvue by 0.6% during the first quarter. Fulton Bank N.A. now owns 78,888 shares of the company's stock worth $1,892,000 after purchasing an additional 465 shares during the period. Scott & Selber Inc. raised its position in shares of Kenvue by 0.4% in the 1st quarter. Scott & Selber Inc. now owns 106,621 shares of the company's stock valued at $2,557,000 after buying an additional 475 shares in the last quarter. SRS Capital Advisors Inc. lifted its holdings in shares of Kenvue by 67.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company's stock worth $30,000 after acquiring an additional 571 shares during the period. Keystone Financial Group boosted its position in shares of Kenvue by 4.8% during the 4th quarter. Keystone Financial Group now owns 12,736 shares of the company's stock worth $272,000 after acquiring an additional 578 shares in the last quarter. Finally, Transatlantique Private Wealth LLC boosted its position in shares of Kenvue by 5.7% during the 4th quarter. Transatlantique Private Wealth LLC now owns 10,680 shares of the company's stock worth $228,000 after acquiring an additional 580 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have recently commented on KVUE shares. UBS Group increased their target price on shares of Kenvue from $24.00 to $25.00 and gave the stock a "neutral" rating in a report on Friday, May 9th. Citigroup reiterated a "neutral" rating on shares of Kenvue in a research report on Friday, June 13th. Evercore ISI initiated coverage on shares of Kenvue in a research report on Monday, March 24th. They issued an "in-line" rating and a $25.00 target price on the stock. Redburn Atlantic initiated coverage on shares of Kenvue in a research note on Thursday, April 10th. They set a "neutral" rating and a $23.50 target price on the stock. Finally, Barclays upped their price target on shares of Kenvue from $22.00 to $23.00 and gave the stock an "equal weight" rating in a report on Monday, May 12th. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $25.33.

Kenvue Trading Up 0.6%

Kenvue stock traded up $0.12 during trading hours on Friday, reaching $21.02. The stock had a trading volume of 6,093,067 shares, compared to its average volume of 16,125,551. The company has a fifty day simple moving average of $22.61 and a 200-day simple moving average of $22.31. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $25.17. The stock has a market cap of $40.32 billion, a PE ratio of 38.21, a PEG ratio of 3.27 and a beta of 0.83. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.86 and a quick ratio of 0.60.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.23 by $0.01. The company had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.69 billion. Kenvue had a net margin of 6.90% and a return on equity of 20.87%. Kenvue's revenue was down 3.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.28 earnings per share. Analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th were given a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a yield of 3.90%. The ex-dividend date of this dividend was Wednesday, May 14th. Kenvue's dividend payout ratio (DPR) is 149.09%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.